Karah Herdman Parschauer - Apr 21, 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Stock symbol
ANEB
Transactions as of
Apr 21, 2022
Transactions value $
$0
Form type
4
Date filed
10/3/2022, 07:56 PM
Previous filing
Mar 8, 2022
Next filing
Sep 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +30.4K $0.00 30.4K Apr 21, 2022 Common Stock 30.4K $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the option vests on March 1, 2023. Thereafter, 1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested.